Palatin Technologies, Inc. (LON:0KF3)
London · Delayed Price · Currency is GBP · Price in USD 9.80
-0.79 (-7.46%)
Aug 14, 2026, 2:35 PM GMT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of 12.87 million as of August 17, 2026. Its market cap has increased by 122.54% in one year.
Market Cap
12.87M
Enterprise Value
5.58M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.80
ChartMarket Cap Chart
Since January 29, 2018, Palatin Technologies's market cap has decreased from 124.07M to 12.87M, a decrease of -89.63%. That is a compound annual growth rate of -23.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 12.87M | -63.40% |
| Dec 11, 2025 | 35.16M | 61.85% |
| Dec 31, 2024 | 21.72M | -43.72% |
| Dec 29, 2023 | 38.60M | 99.29% |
| Dec 28, 2022 | 19.37M | -79.00% |
| Dec 30, 2021 | 92.25M | -28.03% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 27.39M |
| SkinBioTherapeutics | 25.59M |
| Arecor Therapeutics | 22.47M |
| IXICO | 16.35M |
| Aptamer Group | 13.82M |
| Fusion Antibodies | 13.14M |
| Genflow Biosciences | 12.12M |
| Solvonis Therapeutics | 10.21M |